Skip to main content

Christopher Murray - "Global Burden of Disease 2020"


2022 AADOCR/CADR Annunal Meeting

The 51st Annual Meeting of the AADOCR was held in conjunction with the 46th Annual Meeting of the Canadian Association for Dental Research, from March 14-26 as a hybrid experience with 839 individuals from 18 countries attending in person in Atlanta, GA and 692 individuals from 21 countriesĀ attending virtually.Ā 

The recordings in this library from the meeting are a selection of the science that was to be presented as part of the Annual Meeting. These recordings give you the opportunity to participate in the meeting and hear from leading researchers. The recordings include IADR Distinguished Lecture Series speakers and symposia from a collection of scientific groups and networks.

This session can be purchased as part of the full meeting recordings within the product bundles





The International Association for Dental Research is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.


Christopher Murray
Director, Institute for Health Metrics and Evaluation, University of Washington, Seattle

Distinguished Lecture Series
The Global Burden of Disease Study is a collaboration of over 7,000 scientists who work together to produce annual assessments of disease incidence, prevalence, death and disability for 369 diseases or injuries for 204 countries and subnational units in 22 countries. The analysis also includes the burden of disease attributable to 87 risk factors. Each cycle of the GBD produces a comprehensive time series from 1990 to present. Over the thirty years of the GBD, a highly standardized statistical approach has been developed to deal with a range of common problems such as multiple case definitions, changes in measurement assays, missing data, conflicting data and the challenge of excluded groups in administrative data. The description of the data are available in the Global Health Data Exchange for the over 200,000 data sources used in the study. Key findings in the GBD 2019 highlight the range of major challenges facing the world. GBD 2020 will highlight a key methodological development and the impact of the COVID-19 pandemic. Associated with the GBD, IHME also generates forecasts of the entire GBD to 2050 using a set of validated statistical methods.

Learning Objectives
  • Attendees will expand their knowledge with regard to the global burden of disease.
Presentation Date
March 23, 2022

CE Credits
1 Hour

Sponsored by:
Dentsply-Sirona


Not eligible for individual purchase must purchase as part of a meeting bundle.